Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at December 31, 2014:
- 33,310 shares of Innate Pharma, and
- 233,366.36 euros in cash
As a reminder, at June 30, 2014, the following assets appeared on the liquidity account:
- 23,490 shares of Innate Pharma, and
- 312,376.44 euros in cash
| CP en français | 69.52 KB |
| PR in English | 68.24 KB |